Cargando…

Isoniazid resistance without a loss of fitness in Mycobacterium tuberculosis

The emergence of multi- and extensively drug-resistant tuberculosis (MDR-TB and XDR-TB, respectively) has intensified the critical public health implications of this global disease. The fitness of Mycobacterium tuberculosis (M.tb.) strains exhibiting MDR and XDR phenotypes is of fundamental importan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Jong-Hee, Ammerman, Nicole C., Nolan, Scott, Geiman, Deborah E., Lun, Shichun, Guo, Haidan, Bishai, William R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2012
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3648870/ https://www.ncbi.nlm.nih.gov/pubmed/22434196 http://dx.doi.org/10.1038/ncomms1724

Ejemplares similares

Rv2190c, an NlpC/P60 Family Protein, Is Required for Full Virulence of Mycobacterium tuberculosis
por: Parthasarathy, Geetha, et al.
Publicado: (2012)

Indoleamides are active against drug-resistant Mycobacterium tuberculosis
por: Lun, Shichun, et al.
Publicado: (2013)

Alterations in Phospholipid Catabolism in Mycobacterium Tuberculosis LysX Mutant
por: Maloney, Erin, et al.
Publicado: (2011)

The Impact of Mouse Passaging of Mycobacterium tuberculosis Strains prior to Virulence Testing in the Mouse and Guinea Pig Aerosol Models
por: Converse, Paul J., et al.
Publicado: (2010)

Successful Shortening of Tuberculosis Treatment Using Adjuvant Host-Directed Therapy with FDA-Approved Phosphodiesterase Inhibitors in the Mouse Model
por: Maiga, Mamoudou, et al.
Publicado: (2012)

Synthetic Lethality Reveals Mechanisms of Mycobacterium tuberculosis Resistance to β-Lactams
por: Lun, Shichun, et al.
Publicado: (2014)

Rapid in vivo detection of isoniazid-sensitive Mycobacterium tuberculosis by breath test
por: Choi, Seong Won, et al.
Publicado: (2014)

Aerosol Mycobacterium tuberculosis Infection Causes Rapid Loss of Diversity in Gut Microbiota
por: Winglee, Kathryn, et al.
Publicado: (2014)

Essential Metabolites of Mycobacterium tuberculosis and Their Mimics
por: Lamichhane, Gyanu, et al.
Publicado: (2011)

Gene Expression of Mycobacterium tuberculosis Putative Transcription Factors whiB1-7 in Redox Environments
por: Larsson, Christer, et al.
Publicado: (2012)

Altered cellular infiltration and cytokine levels during early Mycobacterium tuberculosis sigC mutant infection are associated with late-stage disease attenuation and milder immunopathology in mice
por: Abdul-Majid, Khairul-Bariah, et al.
Publicado: (2008)

Discovery of Novel Enhancers of Isoniazid Toxicity in Mycobacterium tuberculosis
por: Lentz, Fabian, et al.
Publicado: (2018)

MDA5 RNA-sensing pathway activation by Mycobacterium tuberculosis promotes innate immune subversion and pathogen survival
por: Bullen, C. Korin, et al.
Publicado: (2023)

Minimum inhibitory concentrations of rifampin and isoniazid among multidrug and isoniazid resistant Mycobacterium tuberculosis in Ethiopia
por: Getahun, Muluwork, et al.
Publicado: (2022)

Design, Synthesis and Biological Evaluation of N-phenylindole Derivatives as Pks13 Inhibitors againstMycobacterium tuberculosis
por: Cai, Yanpeng, et al.
Publicado: (2022)

The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis
por: Somoskovi, Akos, et al.
Publicado: (2001)

Impact of Bacterial Genetics on the Transmission of Isoniazid-Resistant Mycobacterium tuberculosis
por: Gagneux, Sebastien, et al.
Publicado: (2006)

Contribution of Efflux to the Emergence of Isoniazid and Multidrug Resistance in Mycobacterium tuberculosis
por: Machado, Diana, et al.
Publicado: (2012)

Effect of efflux pump inhibitors on the susceptibility of Mycobacterium tuberculosis to isoniazid
por: Jaiswal, Indu, et al.
Publicado: (2017)

Glutamine metabolism inhibition has dual immunomodulatory and antibacterial activities against Mycobacterium tuberculosis
por: Parveen, Sadiya, et al.
Publicado: (2023)

Detecting Novel Genetic Variants Associated with Isoniazid-Resistant Mycobacterium tuberculosis
por: Shekar, Sandhya, et al.
Publicado: (2014)

Nitrite impacts the survival of Mycobacterium tuberculosis in response to isoniazid and hydrogen peroxide
por: Cunningham-Bussel, Amy, et al.
Publicado: (2013)

Novel Isoniazid-Carborane Hybrids Active In Vitro against Mycobacterium tuberculosis
por: Różycka, Daria, et al.
Publicado: (2020)

Retraction: Isoniazid and Rifapentine Treatment Eradicates Persistent Mycobacterium tuberculosis in Macaques
Publicado: (2021)

In silico analyses of isoniazid and streptomycin resistance-associated mutations in Mycobacterium tuberculosis
por: Dasoondi, Rushikesh Singh, et al.
Publicado: (2023)

The Two-Domain LysX Protein of Mycobacterium tuberculosis Is Required for Production of Lysinylated Phosphatidylglycerol and Resistance to Cationic Antimicrobial Peptides
por: Maloney, Erin, et al.
Publicado: (2009)

Glutamine metabolism inhibition has dual immunomodulatory and antibacterial activities against Mycobacterium tuberculosis
por: Parveen, Sadiya, et al.
Publicado: (2023)

Detection of Rifampicin- and Isoniazid-Resistant Mycobacterium tuberculosis Using the Quantamatrix Multiplexed Assay Platform System
por: Wang, Hye-young, et al.
Publicado: (2018)

Binding of activated isoniazid with acetyl-CoA carboxylase from Mycobacterium tuberculosis
por: Unissa, Ameeruddin Nusrath, et al.
Publicado: (2011)

Isoniazid Inhibits the Heme-Based Reactivity of Mycobacterium tuberculosis Truncated Hemoglobin N
por: Ascenzi, Paolo, et al.
Publicado: (2013)

Genetic Mutations Associated with Isoniazid Resistance in Mycobacterium tuberculosis: A Systematic Review
por: Seifert, Marva, et al.
Publicado: (2015)

Para-aminosalicylic acid increases the susceptibility to isoniazid in clinical isolates of Mycobacterium tuberculosis
por: Zhang, Tingting, et al.
Publicado: (2019)

Two Novel katG Mutations Conferring Isoniazid Resistance in Mycobacterium tuberculosis
por: Hsu, Li-Yu, et al.
Publicado: (2020)

Diagnostic performance of DNA microarray for detecting rifampicin and isoniazid resistance in Mycobacterium tuberculosis
por: Sun, Bingqi, et al.
Publicado: (2021)

Highly Sensitive Detection of Isoniazid Heteroresistance in Mycobacterium Tuberculosis by Droplet Digital PCR
por: Zheng, Yang, et al.
Publicado: (2022)

In vitro modeling of isoniazid resistance mechanisms in Mycobacterium tuberculosis H37Rv
por: Dokrungkoon, Thanadon, et al.
Publicado: (2023)

Design, synthesis and evaluation of novel indole-2-carboxamides for growth inhibition of Mycobacterium tuberculosis and paediatric brain tumour cells
por: Alsayed, Shahinda S. R., et al.
Publicado: (2021)

Isoniazid resistance levels of Mycobacterium tuberculosis can largely be predicted by high-confidence resistance-conferring mutations
por: Lempens, Pauline, et al.
Publicado: (2018)

Isoniazid resistance and the point mutation of codon 463 of katG gene of Mycobacterium tuberculosis.
por: Shim, T. S., et al.
Publicado: (1997)

Evaluation of Biochip System in Determining Isoniazid and Rifampicin Resistances of Mycobacterium Tuberculosis in Sputum Samples
por: Lu, Wei, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ssgdbj2ah0mainjm9nv1jf3irs